Related Experiment Video
Updated: Dec 14, 2025
11:36
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
3.3K
Ceftriaxone-Induced Immune Hemolytic Anemia.
Anil Singh1, Namrata Singhania2, Amit Sharma3
1Hospital Medicine, Geisinger Community Medical Center, Scranton, USA.
Cureus
|July 24, 2020
Summary
Ceftriaxone, a common antibiotic, can rarely cause immune hemolytic anemia (IHA), a serious condition. This case highlights the importance of early diagnosis and management of this rare ceftriaxone side effect.
Area of Science:
- Pharmacology
- Hematology
- Internal Medicine
Background:
- Ceftriaxone is a widely prescribed third-generation cephalosporin antibiotic used for various bacterial infections.
- Allergic reactions to ceftriaxone are typically mild, but rare, severe complications can occur.
- Ceftriaxone-induced immune hemolytic anemia (IHA) is a rare but potentially life-threatening adverse drug reaction.
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
351
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
351
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
113
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
113